liver-cancer

Documents about liver-cancer

• TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma#807921ClinicalTrials.gov
• A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma#832588ClinicalTrials.gov
• Effect of tDCS on Chronic Abdominal Visceral Pain in HCC Patients#855340ClinicalTrials.gov
• A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma#855438ClinicalTrials.gov
• Modified Short-Course Radiotherapy Combined With Immunochemotherapy and Targeted Therapy as First-Line Treatment for MSS Metastatic Colorectal Cancer#321692ClinicalTrials.gov
• Metabolic dysfunction‐associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad#129425HAL (France)
• Fine-tuned lightweight language models for structured extraction of liver cancer imaging free-text report: a comparative analysis with existing large language models.#148246NCBI PubMed Central
• FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma#226259ClinicalTrials.gov
• <i>RAMP3</i> is a Prognostic Indicator of Liver Cancer and Might Reduce the Adverse Effect of <i>TP53</i> Mutation on Survival#384019CiNii
• Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer#857754ClinicalTrials.gov
• Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With HCC#871231ClinicalTrials.gov
• Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2)#893272ClinicalTrials.gov
• Primary liver cancer in Georgia: Seven years’ experience following the launch of the Hepatitis C Elimination Program, 2015–2022#141265PLOS
• Single-cell RNAseq reveals adverse metabolic transcriptional program in intrahepatic cholangiocarcinoma malignant cells#288292HAL (France)
• Food and nutrition literacy and diet self-efficacy among patients with liver cancer: latent profile analysis, associated factors, and an exploratory examination of gender differences.#354525NCBI PubMed Central
• Photoacoustic Probe for Rapidly Recognizing Superoxide Anion Affording Visualized Tracing of Ferroptosis-Mediated Acute Liver Injury#382042Figshare
• Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced HCC#398304ClinicalTrials.gov
• 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer#628533ClinicalTrials.gov
• Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)#865996ClinicalTrials.gov
• Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction#982790ClinicalTrials.gov
• ABT-751 in Treating Young Patients With Refractory Solid Tumors#803060ClinicalTrials.gov
• Plasma Folate, Vitamin B12, and Homocysteine and Cancers of the Esophagus, Stomach, and Liver in a Chinese Population#814636eScholarship
• Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer#407741ClinicalTrials.gov
• Dietary Citrus Flavonoid Hesperetin Attenuates Metabolic Dysfunction–Associated Steatotic Liver Disease via Modulation of MAPK–RARα Axis#471728Figshare
• Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)#901167ClinicalTrials.gov
• HCC Risk and Monitoring in Patients With Type 2 Diabetes#914772ClinicalTrials.gov
• PS101-mediated ACT With Chemotherapy in Liver Metastases From Cancer of Gastrointestinal Origin#905285ClinicalTrials.gov
• Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study#886562ClinicalTrials.gov
• HN1-mediated activation of lipogenesis through Akt-SREBP signaling promotes hepatocellular carcinoma cell proliferation and metastasis#342290KOASAS: KAIST Open Access Self-Archiving System
• Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis#661944Europe PMC
• A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC#898608ClinicalTrials.gov
• Adding IL-2 to Tebentafusp to Eradicate Cancer Progression#900674ClinicalTrials.gov
• A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment#981143ClinicalTrials.gov
• Stoking an anti-liver cancer immune response with cryoablation plus an intratumoral TLR9 agonist and dual checkpoint inhibitors#1053160Europe PMC
• Raw Garlic Consumption and Risk of Liver Cancer: A Population-Based Case-Control Study in Eastern China#780451eScholarship
• Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis#874729ClinicalTrials.gov
• Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery#850868ClinicalTrials.gov
• Comparison of Central Venous Pressures (CVPs) Measured From Peripherally Inserted Central Catheters (PICC) and CICC in Liver Transplantation Recipients#894195ClinicalTrials.gov
• Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma#811800ClinicalTrials.gov
• An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer#849852ClinicalTrials.gov
• Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE#863236ClinicalTrials.gov
• Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects#1030629ClinicalTrials.gov
• Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab#1045747ClinicalTrials.gov
• Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial#252994ClinicalTrials.gov
• Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer#366587ClinicalTrials.gov
• HIF1 inhibition targets tumoral and myeloid cells, and is a promising therapy for metastatic castration-resistant prostate cancer#377974HAL (France)
• pgRNA-m⁶A levels associate with HBV replication and liver function#661908Figshare
• Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma#838046ClinicalTrials.gov
• The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead#993925ClinicalTrials.gov
• Reprogramming M2 macrophages via TLR7/8 agonist-loaded hollow MnO₂ nanovehicles to suppress the progression of liver cancer#1001747PLOS